Clinical Trial Update: Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating standard of care with or without atorvastatin for prevention of graft-versus-host disease in matched unrelated donor bone ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Loyola University | Conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia | Phase 3 | Status: WITHDRAWN